- About FSPH
- Current Students
- Prospective Students
- Alumni Affairs
- Give to the School
|Departments||Type of Faculty|
|Health Policy and Management||Full Time|
Corrina Moucheraud is an Assistant Professor in the Department of Health Policy & Management. She is a global health policy and systems researcher. Her main areas of work include the processes and outcomes of policy implementation at the global and national levels; and incorporating health system information into quantitative methodologies for evidence-based decision-making in low-resource settings. She has participated in research across many countries, particularly in Asia and sub-Saharan Africa.
Lancet Commission on Essential Medicines Policies. (2016). Essential medicines for universal health coverage. Lancet.
Moucheraud C, Owen H, Singh NS, et al. (2016). Countdown to 2015 country case studies: what have we learned about processes and progress towards MDGs 4 and 5? BMC Public Health. 16(S2): 794.
Moucheraud C, Sparkes S, Nakamura Y, et al. (2016). PEPFAR Investments In Governance And Health Systems Were One-Fifth Of Countries' Budgeted Funds, 2004-14. Health Affairs, 35(5): 847-55.
Moucheraud C, Wirtz VJ, Reich MR. (2015). Evaluating the quality and use of economic data in decisions about essential medicines. Bulletin of the World Health Organization, 93(10): 693-699.
Moucheraud C, Gass J, Lipsitz S, et al. (2015). Bedside availability of prepared oxytocin and rapid administration after delivery to prevent postpartum hemorrhage: An observational study in Karnataka, India. Global Health Science and Practice, 3(2): 300-304.
Finlay J, Moucheraud C, Goshev S, et al. (2015). The effects of maternal mortality on infant and child survival in rural Tanzania: A cohort study. Maternal & Child Health Journal.
Moucheraud C, Worku A, Molla M, et al. (2015). Consequences of maternal mortality on infant and child survival: A 25-year longitudinal analysis in Butajira Ethiopia (1987-2011). Reproductive Health, 12(S1): S4.
Cohen JL, Yadav P, Moucheraud C, et al. (2013). Do factory-gate subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania. PLoS ONE, 8(7): e70713.